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ABSTRACT:  
Rearrangements of the actin cytoskeleton are regulated in part by dynamic localised 
activation and inactivation of Rho family small GTPases. SWAP70 binds to and 
activates the small GTPase RAC1 as well as binding to filamentous actin and PIP3. 
We have developed an encoded biosensor, which uses Forster Resonance Energy 
Transfer (FRET) to reveal conformational changes in SWAP70 in live cells. SWAP70 
adopts a distinct conformation at the plasma membrane, which in migrating glioma 
cells is enriched at the leading edge but does not always associate with its PIP3-
dependent translocation to the membrane. This supports a role for SWAP70 in 
positive feedback activation of RAC1 at sites of filamentous actin, PIP3 and active 
RAC1. 
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INTRODUCTION 
Rho family small GTPases regulate many aspects of cell adhesion and cytoskeletal 
organisation [1-3]. Their localised, dynamic and reversible switching between 
inactive and active states is under complex control with key players being activating 
Guanine Nucleotide Exchange Factors (GEFs) and inactivating GTPase activating 
Proteins (GAPs). Canonical GEFs promote release of bound GDP from the GTPase, 
allowing binding of abundant GTP and activation, whereas GAPs promote GTP 
hydrolysis, leading to an inactive state [3]. 
SWAP70 (Switch Associated Protein - 70) is a multi-domain protein containing an N-
terminal potentially calcium-binding EF hand domain, a Pleckstrin Homology (PH) 
domain able to bind selectively to PIP3 and PI(3,4)P2, a Dbl Homology (DH) domain 
and a C-terminal actin-binding motif. The PH and DH domain sequences show that 
SWAP70 is related to a conserved family of GEFs although its activity to catalyse 
exchange is controversial [4-6].First identified as part of the B lymphocyte class 
switching complex [7], SWAP70 is expressed widely and plays roles which influence 
several distinct cellular process. These include cell migration, adhesion and invasion 
[6, 8, 9], phagocytosis [4, 10], endothelial permeability [11] and bone resorption and 
podosome formation in osteoclasts [12, 13]. The molecular basis of many of these 
cellular functions seems to be local activation of small GTPases, particularly RAC1. 
It has been proposed that this is achieved directly by GEF activity of the SWAP70 
DH domain, which is evolutionarily conserved across many eukaryotes including 
plants [14, 15] although the observed strong binding of SWAP70 to RAC1-GTP and 
its weak binding to the unliganded GTPase support other proposed mechanisms by 
which SWAP70 promotes RAC1 activation. Additionally, potentially GEF-
independent functions including bundling and tethering actin have also been 
proposed [10, 16]. 
The localised activation of RAC1 by a large and diverse group of GEFs has been 
heavily studied particularly in the context of cell migration. Several RAC1 activating 
GEFs have been shown to bind to the Class I Phosphoinositide 3–Kinase (PI3K) lipid 
product phosphatidylinositol 3,4,5-trisphosphate (PIP3) thus mediating the frequently 
observed PI3K-dependent activation of RAC1 [17, 18]. Furthermore, demonstration 
of the direct activation of the PI3K catalytic subunit p110by RAC1 has helped 
provide a stronger mechanistic basis for proposed positive feedback loops involving 
activated PI3K and RAC1 [19-22]. 
The localisation of the active and inactive pools of GTPases and the proteins which 
regulate them is key to their function and experimental methods to reveal these 
activation events in living cells are challenging but rewarding [23, 24]. Here we 
describe the construction of a FRET based reporter, which allows the first analysis of 
the dynamic regulation of SWAP70 in living cells. This reveals local conformational 
changes in SWAP70, which mirror the activation of RAC1 at the leading edge of 
migrating cells and provides new insights into its function. 
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MATERIALS AND METHODS 
Plasmid constructs and cloning 
The FRET standards: C5V and CTV; and control vector mVenus-C1 were purchased 
from Addgene. The CFP control vector, mTurquoise-C1, was subcloned from the 
FRET vector backbone F35 (kindly provided by Dr Carsten Schultz, EMBL [25]. The 
SWAP70 protein expressed throughout this study is human SWAP70 isoform 1, 
Consensus Coding Sequence CCDS31426. The FRET biosensor (later termed 
SWAP70-R) for wild-type SWAP70 was cloned by PCR amplification from a 
SWAP70 cDNA provided by the I.M.A.G.E. consortium, using primers 5’ 
GACCGGTGGGAGCTTGAAGGAGGAGCTGC 3’ and 5’ 
CAACGCGTCTCCGTGGTCTTTTTCTCTTTCCAG 3’ and then inserting it into FRET 
backbone F35 using AgeI and MluI. SWAP70-R230C FRET biosensor was created 
by site directed mutagenesis of SWAP70-WT FRET biosensor using primers: 5’ 
AAAACTGGACTGAATGTTGGTTTGTTTTAAAACCCAA 3’ and 5’ 
TTGGGTTTTAAACAAACCAACATTCAGTCCAGTTTT 3’.  
Cell culture 
All the cells lines used in this study were cultured in DMEM supplemented with 10% 
FBS (Sigma), 2 mM glutamnine (Life Technologies) and non-essential amino acids 
(Life Technologies) at 37oC in 5% CO2 95%air (v/v). For microscopy experiments 
cells were cultured and maintained at low cell density (20%-30%) in phenol red free 
media.  
Western blotting 
For protein expression analysis, cell lysates were prepared by using ice-cold lysis 
buffer (25mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP40, 1 mM EGTA, 1 mM EDTA, 
5 mM sodium pyrophosphate, 10 mM beta-glycerophosphate, 50 mM sodium 
fluoride, 0.2 mM PMSF, 1 mM benzamidine, 0.1% betamercaptoethanol) followed by 
centrifugation at 14,000 rpm for 20 minutes at 4oC. Supernatants were subjected to 
protein estimation using Bradford’s assay. Equal amounts of proteins from each 
lysate were resolved by SDS-PAGE using pre-cast 4%- 12% Bis-Tris gels (Life 
Technologies), transferred  onto methanol activated PVDF membrane (Perkin Elmer) 
and blotted for SWAP70 and GAPDH using their respective primary antibodies (α- 
SWAP70, 1:1000, abcam #89605;  and α-GAPDH, 1:10,000, Millipore #MAB374). 
Bound primary antibodies were detected using HRP-conjugated goat anti-mouse IgG 
antibody (Invitrogen, Thermo scientific).   
Cell transfection and staining 
For all microscopy experiments, cells (150,000 cells in case of U87MG or 300,000 
cells in case of Swiss-3T3 cells) were seeded onto 25 mm cover slips placed in each 
well of six well plate. Cells were transfected 24 hours later using Lipofectamine-2000 
(Life Technologies) in Opti-MEM (Life Technologies) as per manufacturer’s 
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instructions. 24 hours post-transfection media was changed and 48 hours post-
transfection cells were imaged live or fixed. For some experiments Swiss-3T3 cells 
were serum starved after 48 hours of transfection for a further 24 hours before 
imaging or fixation. Similarly, for some experiments, U87MG cells were treated with 
some inhibitors 48 hours post-transfections before imaging or fixation. For each 
FRET experiment, cells were transfected with plasmid encoding FRET biosensor 
and also with control vectors: mTurquoise-C1 and mVenus-C1 for SBT calculation 
purpose; and with FRET standards: C5V and CTV. For fixed cell experiments, cells 
expressing Venus or SWAP70 (WT or R230C) were permeabilised using 0.2% Triton 
in PBS for 5 minutes followed by two washes with PBS. The permeablised cells were 
then stained for actin using Alexa Fluor 633 Phalloidin (Thermo Fisher Scientific) for 
20 minutes at RT followed by two washes with PBS.  
Live cell imaging 
All the live cell imaging or FRET experiments were performed on Olympus IX-81 
wide-field microscope equipped with Olympus CellXcellenceR acquisition software, 
an ImageEM EM-CCD 512 x 512 camera (Hamamatsu UK) and an Olympus X 60 
APON 1.45 NA oil lens with a resulting pixel size of 266 nm. For data acquisition, 
cells expressing FRET probes, FRET standards or Donor (i.e. mTurquoise) or 
acceptor (i.e. Venus) were imaged in three different channels: (1) Donor channel: 
excitation 430 nm and emission 470 nm (i.e. excitation peak and emission peak 
respectively for mTurquoise and Cerulean), (2) Acceptor channel: ex. 500 nm and 
em. 530 nm (i.e. excitation peak and emission peak respectively for Venus), and (3) 
FRET channel: ex. 430 nm and em. 530 nm. The excitation source (150W mercury-
xenon MT20-E illumination system) intensity, EM gain, and exposure time were the 
same for donor excitation and acceptor excitation in all the samples across one 
experiment. 
Fixed cell imaging 
Cells were fixed using 4% paraformaldehyde in PBS for 20 minutes at RT, followed 
by two washes with PBS. All fixed cell imaging was performed on Leica SP5 SMD 
confocal laser scanning microscope (CLSM) using a 63X 1.4 NA HC PL Apo oil 
immersion objective lens and a pinhole set to 1 Airy unit. 512 nm and 633 nm lasers 
were used to excite Venus and Alexa Fluor 633 Phalloidin probes, respectively. 
Emission was detected using a photomultiplier tube (PMT) set to a gain of 600-800 
V.  
Image processing and analysis 
All image processing and analysis were performed using Fiji (ImageJ). The FRET 
efficiency images were generated using an ImageJ based plugin PFRET (purchased 
from KCCI, UVa, Virgnia, USA).  
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RESULTS 
Development of a FRET-based SWAP70 conformation reporter 
The activity state of SWAP70 and other multi-domain GEF family members is 
thought to be regulated through localised transient binding to specific regulatory 
lipids and proteins [1]. For most of these proteins, including SWAP70, protein 
modifications such as phosphorylation which are stable and correlate with activity 
have not been identified, making it difficult to analyse the activation state of these 
proteins. A simple hypothesis seems that the regulation of SWAP70 is associated 
with significant changes in the conformation of the enzyme upon local binding to 
partner proteins and lipids. Therefore, we elected to design encoded reporter 
constructs with the aim of revealing transient localised changes in protein 
conformation by engineering modified SWAP70 proteins with cyan and yellow 
fluorescent proteins (CFP and YFP) fused to the N and C-termini respectively. This 
allows localised changes in protein conformation and the relative position of the two 
termini to be revealed by changes in the efficiency of FRET occurring between the 
CFP and YFP, and has been shown to be successful with other proteins [25, 26]. We 
used a large set of previously described CFP-YFP constructs designed using 
mTurquoise and Venus fluorescent proteins (hereafter simplified as CFP and YFP 
respectively) with a range of different linkers [25]. Into this backbone series, we 
inserted a cDNA encoding one of several reported PIP3-regulated GEF-family 
members: SWAP70, DEF6 or TIAM1. 21 different CFP-GEF-YFP expression vectors 
were constructed, transiently transfected into human U87MG glioma cells and 
subjected to FRET analysis in unselected live cells. Most of the 21 constructs were 
rapidly rejected because FRET was either very low or because uniform FRET was 
observed in every cell analysed. This implies either that systematic localised 
conformational changes are not occurring in these proteins in the conditions of the 
experiment or that the linkage to fluorophores fails to couple changes in protein 
conformation with changes in detectable FRET in these constructs. In contrast, 
several reporters based on SWAP70 showed non-uniform FRET in a large 
proportion of cells and were taken forward for further analysis.  
In the characterisation of these reporter constructs, positive (maximum) and negative 
(minimum) CFP-YFP control FRET constructs were used: C5V has a 5 amino acid 
linker between the fluorescent proteins, showing consistently high FRET whereas 
CTV has a 229 amino acid linker and reports very low FRET (Figure 1). The ability to 
detect dynamic changes in FRET was also tested using a previously characterised 
CFP-DAPK1-YFP control [25] which shows greatly reduced FRET within 3 minutes 
in cells treated with the calcium ionophore ionomycin (Figure S2). The FRET 
efficiency observed with CFP-SWAP70-YFP (hereafter called SWAP70-R) was 
always intermediate between these two controls but in many cells displayed elevated 
FRET efficiency at the cell periphery. Importantly, these areas of elevated FRET 
were frequently observed in locations, which showed no evidence of  enrichment of 
the reporter itself, visualised through either direct YFP or CFP fluorescence (Figure 
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1). The converse observation that regions of the cell enriched in SWAP70-R protein 
frequently displayed low FRET also argues strongly that the FRET signal is not 
simply caused by high local concentrations of the fluorophores. Furthermore, this 
non-uniform FRET pattern was not observed with other constructs capable of FRET 
in these cells (e.g. C5V or DAPK1 controls, Figures 1C, S2, S3). 
 
SWAP70 regulates lamellipodia 
SWAP70 activity has been shown to promote the formation of cellular lamellipodia 
and membrane ruffles [6, 16]. The full length protein was over-expressed in the 
SWAP70-R format, in U87MG glioma cells, which were selected for their low 
expression of the endogenous protein among other glioblastoma cell lines [27] 
(Figure S1). SWAP70-R was seen to be enriched on the peripheral cell membrane of 
many but not all cells and this over-expression led to the formation of prominent 
filopodia and lamellipodia on a substantial minority of cells (Figure 2). Notably, 
introducing an R230C mutation into the PH domain of SWAP70, which has been 
previously shown to abolish binding to the plasma membrane lipid PIP3, [6] impaired 
neither the membrane localisation, nor the ability to drive these membrane 
extensions (Figure 2). The induction of filopodia caused by the expression of 
SWAP70-R is in line with previous studies over-expressing SWAP70 and confirms 
the cellular activity of this construct (Figure 2). The localisation of SWAP70-R was 
also studied in Swiss 3T3 fibroblasts, which have been shown to activate PI3K and 
RAC1 upon PDGF stimulation [28, 29]. We found that in these fibroblasts, evident 
enrichment of SWAP70-R on the plasma membrane was not seen in unstimulated 
cells, but a strong translocation of the protein was observed upon PDGF stimulation. 
This PDGF-stimulated translocation of SWAP70-R in fibroblasts appeared to be 
dependent upon binding to PIP3 and/or PI(3,4)P2 as it was not seen with the non-
binding mutant SWAP70 R230C (Figure 3a and 3b). On the other hand, FRET-
based analysis of the conformation of SWAP70 showed that even in unstimulated 
fibroblasts, a high-FRET sub-population of the protein was observed at the 
peripheral membrane of approximately half of these cells, which displayed little or no 
increase in abundance upon PDGF-stimulation, despite the observed bulk 
translocation of SWAP70-R protein to the cell membrane (Figure 3a). These 
experiments also confirm that tagging with fluorescent proteins and over-expression 
of SWAP70-R do not block PIP3-depenent membrane recruitment. 
 
SWAP70 undergoes conformational regulation at the leading edge of migratory 
U87MG cells 
U87MG glioma cells are PTEN null, display several autocrine growth factor signalling 
loops and are highly motile [30-33]. When SWAP70-R was expressed in these motile 
cells, approximately half of the cells showed some focal peripheral enrichment of the 
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reporter, often in lamellipodia at the migratory leading edge (Figure 4). In the same 
experiments, the majority of cells showed peripheral regions with elevated FRET, 
which often did correspond to regions with evident enrichment of the probe but was 
also often observed in cells in which the probe itself appeared homogeneously 
distributed (Figure 4c). Very similar data were acquired in these experiments using 
the SWAP70 reporter for the R230C mutant (Figure 4). These data imply that the 
SWAP70 reporter protein is able to take up distinct conformations at the membrane 
but that these are not reliant upon binding of its PH domain to PIP3. As SWAP70 has 
been reported to bind both to filamentous actin and to activated RAC1, we 
investigated the relationship between SWAP70 localisation and F-actin and the 
effect of inhibiting class I PI3K or RAC1 (Figure 5). In these experiments we used the 
pan class 1 PI3K inhibitor GDC0941 (also known as pictilisib) [34] and the RAC1 
inhibitor EHT1864 [35]. In accordance with previous data, SWAP70 reporter showed 
a co-localisation with F-actin in Swiss3T3 fibroblasts, which was increased by the 
PIP3-dependent membrane translocation of the protein (Figure 5a). A similar 
constitutive co-localisation of SWAP70-R with F-actin was observed in U87MG cells, 
which was suppressed by inhibition of either PI3K or RAC1 (Figure 5b-c). Similarly, 
SWAP70 R230C showed a  level of co-localisation with F-actin, suggesting that the 
reduced co-localisation caused by PI3K inhibition is not simply caused by dramatic 
changes in cellular migration and to the cytoskeleton. 
DISCUSSION 
We have developed a FRET-based reporter to investigate the localised 
conformational regulation of SWAP70 in live cells. This shows that SWAP70 adopts 
a distinct high-FRET conformation in specific areas of the cell periphery. We also 
see that in polarised migratory cells, this conformation is enriched at the leading 
edge. The lack of correlation of this FRET signal with PI3K-dependent recruitment of 
SWAP70 onto the membrane implies that phosphoinositide-binding of the PH 
domain is neither necessary nor sufficient for the observed changes in SWAP70 
conformation. On the other hand, we do not interpret this and the lack of impact of 
the R230C phosphoinositide binding mutation to mean that PI3K is not involved in 
the conformational activation of SWAP70. We suggest that the simplest explanation 
of the data is that binding to PIP3 and/or PI(3,4)P2 influences the localisation of 
SWAP70 on the plasma membrane, but that the key inputs to conformational control 
are the binding of other co-localised molecules, such as F-actin. We also suggest 
that the high FRET sub-population of SWAP70 revealed within these cells is likely to 
be the active, functionally significant pool capable of activating RAC1 and perhaps 
other GTPases. It is notable here that RAC1 and SWAP70 both appear to be quite 
abundant proteins (e.g. very approximately 500 000 and 50 000 molecules 
respectively per NIH3T3 or U2OS cell [36, 37]). 
Our data are consistent with the previously demonstrated binding of SWAP70 to F-
actin and RAC1 in addition to phosphoinositides and support a model in which 
SWAP70 mediates a positive feedback loop resulting in localised PI3K and RAC1 
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activity [17, 19-21, 38]. Mechanistically, this may also be linked to observations that 
some examples of receptor mediated activation of PI3K appear to require the actin 
cytoskeleton [39, 40]. Notably, it was observed in most of the experiments conducted 
during the study that approximately half of cells expressing SWAP70-R displayed a 
modestly higher FRET efficiency in the nucleus than the cytoplasm, despite 
appearing less abundant in the nucleus (e.g. Fig 3a lower). This implies that the 
nuclear and cytoplasmic localisations may influence the conformation of SWAP70, 
which resides in both compartments [41]. Although we have not followed up this 
observation, it is potentially related to the recognised differential regulation of RAC1 
In the nucleus [42]. 
The enrichment of F-actin, PIP3 and active RAC1 has previously been observed at 
the leading edge of adherent cells during their directed migration [24, 43-45]. 
Similarly, the PI3K-dependent recruitment of SWAP70 to the plasma membrane has 
been observed in growth factor stimulated fibroblasts and shown to be necessary for 
the organisation of F-actin within membrane ruffles in these cells [6]. However, the 
precise roles of SWAP70 and the many other GEF-family member capable of 
activating RAC1 in cell migration is unclear [18]. Our identification of a 
conformationally regulated pool of SWAP70 at the leading edge of migrating cells 
suggests that SWAP70 plays a part linking F-actin and PI3K to a stabilised active 
pool of RAC1 at this location. Our work also provides a new research tool, which is 
able to reveal conformational changes in SWAP70 occurring in live cells and which 
should help determine these detailed contributions of SWAP70 and other GEF family 
members in the control of RAC1 and cytoskeletal remodelling. 
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FIGURE LEGENDS 
 
Figure 1: SWAP70-R shows non-uniform FRET signal in U87MG cells.  
(a) SWAP70 has four domains, an N-terminal EF hand like domain, a PIP3 and/or 
PI(3,4)P2 binding PH domain, a DH domain; and a C-terminal actin binding motif. 
Thediagrams represent the design of the SWAP70-R (WT and PH domain mutant, 
R230C) FRET reporters with CFP variant mTurquoise at the N-terminus and YFP 
variant Venus at the C-terminus. (b) A diagram illustrates the structure of the FRET 
controls: C5V and CTV. C5V has a short linker of the length of 5 amino acids 
between the two fluorophores, which brings two fluorophores within the physical 
limits of FRET occurrence. Whereas, CTV has a 229 amino acid long linker between 
the two fluorophores, permitting a greater spatial separation of the fluorophores. (c) 
U87MG cells were transfected with the expression vectors encoding FRET controls 
or SWAP70-R. Control cells were transfected with expression vectors encoding CFP 
or YFP for the purpose of spectral bleed through corrections.  48 hours post-
transfection cells were imaged using a wide-field microscope. Imaging in donor 
channel (ex. 430 nm and em. 470 nm) (top panel) shows the localization of the 
construct; and the FRET signal calculated with Image J/PFRET (bottom panel). The 
images shown are representative of four independent experiments with at least 6 
cells analyzed per experiment. Scale bar = 15 μm. Positive FRET control, C5V 
shows a uniform high FRET signal (~50%) and negative FRET control, CTV show a 
uniform low FRET signal (<10%) across the cell. SWAP70-R shows a non-uniform 
FRET signal (between 10% and 35%) with higher signal at the cell periphery 
compared to the interior of the cell.  
 
Figure 2: SWAP70-R shows membrane localization and affects cellular 
morphology of U87MG cells independently of its ability to bind to PIP3.  
(a) U87MG human glioma cells were transfected with expression vectors encoding 
SWAP70-R (WT or R230C). Control cells were transfected with expression vectors 
encoding YFP.  24 hours post-transfection cells were imaged using a wide-field 
microscope in acceptor/YFP channel (ex. 500 nm and em. 530 nm) . Scale bar = 15 
μm. Overexpression of SWAP70-R, both WT and R230C, lead to several distinct 
changes, examples of which are shown: membrane enrichment of SWAP70-R (left 
panel), extension of lamellipodia (middle panel) and an increased number of 
filopodia (right panel) compared to control cells. (b) Bar chart shows the percentage 
number of cells having ≥4 filopodia. The quantification is derived from three 
independent experiments and 10 randomly chosen fields of view for each construct 
per experiment. Error bars represent mean ±SEM. Over-expression of both 
SWAP70-WT and SWAP70-R230C significantly increased the number of cells with 
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four or more filopodia compared to control cells (Student’s T-test - p<10-5). The total 
number of cells counted was 488 for SWAP70, 455 for R230C and 421 for YFP. 
 
Figure 3: SWAP70-R reveals a membrane-associated population of SWAP70 
molecules with a distinct conformation, which is unaffected by an observed 
PH domain mediated membrane translocation  
(a) Swiss-3T3 cells were transfected with expression vectors encoding SWAP70-R 
(WT or R230C). Serum starved cells were imaged live, for 2 minutes before 
treatment with PDGF (50 ng/mL) or vehicle for 10 minutes, with the presented 
images being captured immediately prior to stimulation and after 4 minutes. The 
image shows the localization of the reporter (left, blue) and the FRET efficiency 
(right, pink/purple) and are representative of four independent experiments. Scale 
bar = 15 μm. (b) A bar chart showing the percentage of cells showing membrane 
translocation of the SWAP70-R upon treatment with vehicle or PDGF. Error bars 
represent the mean ±SEM of four independent experiments, with 6-8 cells being 
imaged for each construct in each stimulation condition per experiment. Statistical 
significance was calculated using Student’s t-test (unpaired, 2 tailed). 
 
 
Figure 4: SWAP70-R shows a distinct conformation and enrichment at the 
leading edge of the motile U87MG cells which does not correlate strongly with 
its ability to bind PIP3.  
U87MG cells were transfected with expression vectors encoding SWAP70-R (WT 
and R230C). 48-hours post-transfection cells were imaged live (1 frame/min). White 
arrows show the direction of cell movement. Scale bar = 15 μm. (a) SWAP70-R, both 
WT and R230C show high FRET signal on the leading edge of motile U87MG cells 
without or (b) with strong enrichment of the reporter in leading edge lamellipodia. (c) 
Quantification of the imaged cells in terms of motility, localization of SWAP70-R in 
the cell and FRET of SWAP70-R. The error bars represent the mean ±SEM. (D) 
Quantification of the leading edge events of SWAP70-R in motile U87MG cells 
expressed as percentage number of motile U87MG cells showing reporter 
enrichment, high FRET or both on the leading edge of the cells. The error bars 
represent the mean ±SEM. The images shown are representative of five 
experiments with 7-10 cells imaged for each construct per experiment. 
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Figure 5: SWAP70-R shows accumulation in actin rich sites of the cell. Cells 
were transfected with expression vectors encoding SWAP70-R (WT or R230C) 
or YFP as a control.  
(a) Swiss-3T3 cells expressing YFP or SWAP70-R (WT or R230C) were treated with 
vehicle or PDGF (50ng/mL for 10 minutes) post 24 hours of serum starvation. Cells 
were fixed and then stained for endogenous F-actin using phalloidin alexa-633 after 
permeabilization (0.2% triton for 5 minutes). In PDGF stimulated Swiss-3T3 cells, 
SWAP70-R is found enriched on the membrane and actin rich sites (shown by 
arrows). (b) U87MG cells expressing YFP or SWAP70 (WT or R230C) were treated 
with DMSO or PI3K inhibitor (2 μM GDC0941 for 20 minutes) or Rac1 inhibitor (10 
μM EHT1864 for 20 minutes). SWAP70-R (both WT and R230C) show localization in 
actin rich sites. Either PI3K or Rac1 inhibitor reduce/remove the localization of 
SWAP70 in actin rich sites. (c) Bar charts showing the percentage of cells showing 
localization of YFP or SWAP70-R (WT or R230C) in actin rich sites in U87MG cells 
upon treatment with DMSO or PI3K or Rac1 inhibitor (GDC0941 and EHT1864 
respectively). The experiment was performed three times and error bars represent 
the mean  ±SEM. Statistical significance was calculated using Student’s t-test. The 
total number of cells analyzed was for Venus: 27 for DMSO, 24 for GDC0941 and 24 
for EHT1864. SWAP70-WT: 32 for DMSO, 26 for GDC0941 and 21 for EHT1864 
and SWAP70-R230C: 30 for DMSO, 24 for GDC0941 and 28 for EHT1864. 
 
 
